Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities

NCT05311709 is registered in ClinicalTrials.gov with Vestre Viken Hospital Trust as lead sponsor.

NCT NCT05311709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05311709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sotorasib in Advanced KRASG12C-mutated Non-small Cell Lung Cancer Patients With Comorbidities
Lead sponsor
Vestre Viken Hospital Trust
Phase
Phase 2
Overall status
Unknown status
Start date
May 30, 2022
Completion date
March 1, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, cancer, lung, lung cancer, lung cancer stage iv, mutation, nsclc stage iv, nsclc, stage iii